On 7/22/24, vTv Therapeutics Inc (NASDAQ: VTVT) stock enjoyed a major increase of 12.5%, closing at $22.96. Moreover, exceptionally high trading volume at 613% of normal accompanied the advance. The stock has risen 2.0% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, VTVT is expected to continue to be a major Value Eraser.
vTv Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment